AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
-3.65%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.36B
AUM Growth
+$3.36B
(-16%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
27.79%
Holding
302
New
82
Increased
55
Reduced
75
Closed
50
Top Buys
| 1 |
PTC Therapeutics
PTCT
|
$65.3M |
| 2 |
Immunovant
IMVT
|
$39.8M |
| 3 |
AB InBev
BUD
|
$38.9M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
$33.3M |
| 5 |
Charles River Laboratories
CRL
|
$30.6M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$114M |
| 2 |
Pfizer
PFE
|
$76.9M |
| 3 |
Johnson & Johnson
JNJ
|
$50.7M |
| 4 |
Neurocrine Biosciences
NBIX
|
$48.8M |
| 5 |
Incyte
INCY
|
$42.7M |
Sector Composition
| 1 | Healthcare | 66.93% |
| 2 | Consumer Staples | 12.81% |
| 3 | Technology | 8.13% |
| 4 | Consumer Discretionary | 7.55% |
| 5 | Communication Services | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Marriott International Class A Common Stock
MAR
$72.7B
| $6.17M | 0.09% | 31,377 -623 | -2% | -$122K |
|
102
Lyra Therapeutics
LYRA
$11.5M
| $6.06M | 0.09% | 1,550,000 -2,462,036 | -61% | -$9.63M |
|
103
Advantage Solutions
ADV
$593M
| $6M | 0.09% | 2,111,000 | – | – |
|
104
ImmunityBio
IBRX
$2.21B
| $5.87M | 0.09% | +3,476,000 | New | +$5.87M |
|
105
Rockwell Medical
RMTI
$58.9M
| $5.86M | 0.09% | 2,817,000 +2,432,000 | +632% | +$5.06M |
|
106
Wynn Resorts
WYNN
$13.2B
| $5.17M | 0.08% | 56,000 -44,000 | -44% | -$4.07M |
|
107
RH
RH
$4.23B
| $5.16M | 0.08% | +19,535 | New | +$5.16M |
|
|
HYPD
108
Hyperion DeFi, Inc. Common Stock
HYPD
$34.7M
| $5.12M | 0.08% | +3,087,021 | New | +$5.12M |
|
109
Skechers
SKX
$9.48B
| $5.09M | 0.08% | +103,929 | New | +$5.09M |
|
110
M&T Bank
MTB
$31.5B
| $5.06M | 0.08% | 40,000 -10,000 | -20% | -$1.26M |
|
111
Restaurant Brands International
QSR
$20.8B
| $4.69M | 0.07% | +70,367 | New | +$4.69M |
|
112
Western Alliance Bancorporation
WAL
$9.88B
| $4.59M | 0.07% | 99,915 -60,085 | -38% | -$2.76M |
|
113
Tapestry
TPR
$21.2B
| $4.39M | 0.07% | +152,826 | New | +$4.39M |
|
114
Gossamer Bio
GOSS
$562M
| $4.13M | 0.06% | +4,956,000 | New | +$4.13M |
|
115
Portage Biotech
PRTG
$16.4M
| $4.11M | 0.06% | +1,968,105 | New | +$4.11M |
|
|
CKPT
116
DELISTED
Checkpoint Therapeutics
CKPT
| $3.51M | 0.05% | 2,064,000 +651,000 | +46% | +$1.11M |
|
117
Sol-Gel Technologies
SLGL
$63.5M
| $3.48M | 0.05% | 2,135,000 -73,000 | -3% | -$119K |
|
|
KA
118
DELISTED
Kineta, Inc. Common Stock
KA
| $3.16M | 0.05% | 930,000 +54,000 | +6% | +$184K |
|
119
IO Biotech
IOBT
$104M
| $3.03M | 0.05% | +2,148,000 | New | +$3.03M |
|
120
Dare Bioscience
DARE
$27.2M
| $2.99M | 0.05% | +6,470,000 | New | +$2.99M |
|
|
CMPS
121
Compass Pathways
CMPS
$424M
| $2.96M | 0.05% | +400,000 | New | +$2.96M |
|
122
Reviva Pharmaceuticals
RVPH
$30.6M
| $2.93M | 0.04% | 600,000 -224,000 | -27% | -$1.09M |
|
|
CMRX
123
DELISTED
Chimerix, Inc.
CMRX
| $2.76M | 0.04% | 2,872,000 -304,000 | -10% | -$292K |
|
124
Spotify
SPOT
$140B
| $2.61M | 0.04% | +16,873 | New | +$2.61M |
|
125
X4 Pharmaceuticals
XFOR
$84.3M
| $2.57M | 0.04% | 2,356,000 -620,000 | -21% | -$676K |
|